Research published in Pharmacy and Therapeutics suggests patients with obesity can lose at least 5 percent of their body weight after using Contrave for 12 weeksand as much as 11.5 percent after 56 weeks
Patients on lipotropic protocols are simultaneously dieting, exercising, and being weighed by a clinician every few weeks
Common side effects include gastrointestinal symptoms like nausea, vomiting, diarrhea, and constipation, as well as hypoglycemia and injection site reactions
JCO Clinical Cancer Informatics 2022, 6: e2100170
Before beginning your GLP-1 Treatments, Semaglutide or Tirzepatide medical weight loss program, you should communicate any medical conditions, prescription medications, supplements, and allergies to Dr